BNF for Children January 2024 Update

This update contains 4 significant changes and 2 new monographs.

Significant Changes:

Budesonide with formoterol (Symbicort 200/6 Turbohaler®): updated to include dosing as reliever therapy for mild asthma.
Co-cyprindiol: update to contra-indications and cautions for use.
Factor IX fraction, dried: name change to factor IX .
Isotretinoin (Roaccutane®): introduction of new safety measures, including additional oversight of the initiation of treatment for patients under 18 years of age [MHRA/CHM advice].

New Monographs: